Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples